OOIR: Observatory of International Research

Papers

(The H4-Index of Bioorganic & Medicinal Chemistry Letters is 25. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Editorial Board	117
Pyrazolo-1-carbothioamides as EGR-1–DNA binding disruptors	80
Armeniaspirol analogues disrupt the electrical potential (ΔΨ) of the proton motive force	70
Graphical Abstract TOC	53
Editorial Board	45
Neuropilin 1-targeted near-infrared fluorescence probes for tumor diagnosis	42
Contents continued	39
Synthesis and biological evaluation of novel 1,2,3,4-tetrahydro-β-carboline derivatives as potential antibacterial agents	35
Studies on in vitro modulatory effects to base excision repair enzymes induced by small molecule binding to Deaminated CAG repeat hairpin	33
Design, synthesis and biological evaluation of alginate oligosaccharide derivatives	33
Design and evaluation of anaplastic lymphoma kinase degraders using a covalent fumarate handle	32
Phytochemical investigation of Asarum sieboldii var. seoulense and the phenotypic profiles of its constituents against a Parkinson’s Disease olfactory cell line	32
Discovery of a macrocyclic FAK inhibitor GZD-257 for treatment of glioblastoma	30
Epigallocatechin and epigallocatechin-3-gallate are not inhibitors of tyrosinase	30
Design and structural optimization of thiadiazole derivatives with potent GLS1 inhibitory activity	30
4′-O-methoxyethyl-2′-deoxy-uridine and cytidine ribonucleotides improve duplex stability, nuclease resistance, and elicit efficient knockdown of Bcl-2 expression	30
Synthesis of novel 5,6,6a,8-tetrahydro-1H-benzo[5,6]oxepino[2,3,4-de]quinoline fused iminosugars as uncompetitive inhibitors against α-glucosidase	29
Green synthesis and anti-biofilm activities of 3,5-disubstituted isoxazoline/isoxazole-linked secondary sulfonamide derivatives on Pseudomonas aeruginosa	29
Improved synthesis and anticancer activity of a potent neuronal nitric oxide synthase inhibitor	29
Discovery of structural diverse reversible BTK inhibitors utilized to develop a novel in vivo CD69 and CD86 PK/PD mouse model	27
New class of fused [3,2-b][1,2,4]triazolothiazoles for targeting glioma in vitro	27
Synthesis and evaluation of novel oxanthrene scaffold-derived oxazolidinone antibiotics with potent antitubercular activity and low cellular toxicity	26
Design, synthesis and characterizations of prodrugs of brexanolone	25
Recent progress in synthetic strategies to develop potent, HDAC8-selective, small-molecule inhibitors	25
Development of a highly potent and selective degrader of LRRK2	25

Design, synthesis and biological evaluation of tanshinone IIA derivatives as NLRP3 inflammasome inhibitors